PACS Group, Inc. (NYSE:PACS – Get Free Report) has earned an average rating of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $58.80.
PACS has been the subject of several analyst reports. UBS Group raised their price target on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Truist Financial set a $62.00 price objective on shares of PACS Group in a research note on Wednesday, September 2nd. Royal Bank Of Canada increased their price objective on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Finally, Weiss Ratings lowered shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th.
Read Our Latest Analysis on PACS Group
PACS Group Price Performance
PACS Group (NYSE:PACS – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. As a group, equities research analysts anticipate that PACS Group will post 2.13 earnings per share for the current year.
Insider Activity
In other news, Director Mark Hancock sold 155,682 shares of the business’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $42.47, for a total value of $6,611,814.54. Following the transaction, the director directly owned 53,518,884 shares of the company’s stock, valued at $2,272,947,003.48. The trade was a 0.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 91,306 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $43.92, for a total value of $4,010,159.52. Following the sale, the chief executive officer owned 54,754,110 shares in the company, valued at approximately $2,404,800,511.20. The trade was a 0.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 1,322,655 shares of company stock valued at $57,456,006. Corporate insiders own 70.10% of the company’s stock.
Hedge Funds Weigh In On PACS Group
Institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. bought a new position in PACS Group during the first quarter worth $3,171,000. Smith Group Asset Management LLC acquired a new stake in PACS Group in the first quarter worth $771,000. Maven Securities LTD bought a new stake in PACS Group in the fourth quarter valued at $960,000. Bank of New York Mellon Corp bought a new stake in PACS Group in the second quarter valued at $8,196,000. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of PACS Group during the first quarter valued at about $6,762,000.
PACS Group Company Profile
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
See Also
- Five stocks we like better than PACS Group
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
